Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study

Ovarian cancer remains the leading cause of mortality among women with gynecologic malignancies. Many patients have achieved complete clinical re-mission at the conclusion of primary treatment with surgical debulking and platinum- and taxane-based chemotherapy.